Neeharika Thottempudi, MBBS

Neeharika Thottempudi practices at Carson Tahoe Advanced Neurosurgery - HOPD in Carson City, Nevada.

Neeharika Thottempudi's NPI, 1003313511, was assigned on April 11, 2018. Neeharika Thottempudi graduated from Andhra Medical College NTR in 2015. Neeharika Thottempudi holds Texas license BP10063406.

Neeharika Thottempudi's primary practice is Carson Tahoe Advanced Neurosurgery - HOPD, at 1470 Medical Pkwy, Carson City, NV 89703.

Neeharika Thottempudi's primary practice is Carson Tahoe Advanced Neurosurgery - HOPD in Carson City, Nevada. Neeharika Thottempudi is also affiliated with Carson Tahoe Regional Medical Center. The medical group on file is Carson Tahoe Medical Group. Dmand AI also links Neeharika Thottempudi to 4 more hospitals, 2 group practices and clinics, 2 medical groups and 1 home health agency, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Neeharika Thottempudi practices, 9 sites in all. Vendor and product names are available with a free account.

Neurology is Neeharika Thottempudi's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Neeharika Thottempudi is board certified in neurology by the American Board of Psychiatry and Neurology. Dmand AI has Neeharika Thottempudi's licenses on file in 3 states: Texas, Nevada and Connecticut.

CMS data shows 682 Medicare services from Neeharika Thottempudi across 7 procedure codes in 2024, for 370 Medicare patients. Medicare paid $66,032 for them.

CMS counts 370 Medicare patients who saw Neeharika Thottempudi in 2024. The largest group is 75 to 84, with 150 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 11% are also on Medicaid. Their average risk score is 1.14, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Neeharika Thottempudi's median patient age at 72, with 59% women.

In 2024, Neeharika Thottempudi wrote 869 Medicare Part D claims for 304 patients. 88% of them were for generic drugs. CMS names the drug for 663 of them, across 23 drugs with 11 or more claims each, at $82,955 in total drug cost. In 2023, CMS named 63 claims across 3 drugs.

Neeharika Thottempudi accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Neeharika Thottempudi as offering telehealth.

Dmand AI links 13 papers to Neeharika Thottempudi, published from 2018 to 2023. 2021 was the busiest year, with 4. The most frequent topics are COVID-19 and Pandemics. Neeharika Thottempudi has published most often in Cureus. Neeharika Thottempudi's most frequent co-authors are Xiang Fang, MD, PhD, Bhanu Gogia, MD and Todd Simon Masel, MD.

CMS Open Payments shows 422 general payments to Neeharika Thottempudi from 43 drug and device companies from 2018 to 2025. Food and beverage make up the largest share, 100% of the total. Abbvie Inc. paid the most, $1,397.

Dmand AI lists 1 award for Neeharika Thottempudi, most recently AB Baker Teacher Recognition Award in 2025.

Neeharika Thottempudi graduated from Andhra Medical College NTR in 2015. Neeharika Thottempudi is a member of AAN and AHA.

Neeharika Thottempudi is in network with 13 carriers, including Aetna, Elevance and United Healthcare. Medicare plans come from the most carriers, 9. Check the plan with the practice before a visit.